| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 3 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | Brazil | 2 | |
| #4 | China | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | Republic of Korea | 1 | |
| #7 | New Zealand | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Winqvist Ola | 13 |
| #2 | Thoern Magnus | 9 |
| #3 | Thorn Magnus | 4 |
| #4 | Ola Winqvist | 2 |
| #5 | Magnus Thoern | 1 |
| #6 | Magnus Thorn | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2010015161A1 | Composition Comprising In Vitro Expanded T-Lymphocytes and Vessel Formation Inhibitors Suitable in the Treatment of Cancer | |
| WO2008104380A2 | Multiplex detection of tumour cells using a panel of agents binding to extracellular markers | |
| CA2634169A1 | Method for treating disseminated cancer | |
| KR20080091772A | Improved method for expansion of tumour-reactive t-lymphocytes for immunotherapy of patients with cancer | |
| EP1808200A2 | Cancer immuno-therapy |